Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 3/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1406231 | 0.89 | TSHR (0.55) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL8686256 | 0.89 | TSHR (0.55) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL28576166 | 0.86 | L3MBTL1 (0.45) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL28576167 | 0.86 | L3MBTL1 (0.49) | MGAMGAASIMGAM2KMT2A | |
| SCHEMBL11121706 | 0.86 | TSHR (0.50) | TSHRMGAMGAASIMGAM2 | |
| SCHEMBL3752221 | 0.85 | ALDH1A1 (0.38) | TSHRMGAMGAASIMGAM2 | |
| SCHEMBL17190718 | 0.85 | TSHR (0.41) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL17190717 | 0.85 | LMNA (0.42) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL17995485 | 0.83 | TSHR (0.40) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL28634576 | 0.80 | TSHR (0.44) | TSHRSLC1A1MGAMGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112028755-B | Method for preparing 1,3 cyclohexanedione | 山东亘元生物科技有限公司 | 2022-05-24 | — | — | CN | disclosed |
| CN-112028755-B | Method for preparing 1,3 cyclohexanedione | 山东亘元生物科技有限公司 | 2022-05-24 | — | — | CN | disclosed |
| CN-113336629-A | Preparation process of 1,3 cyclohexanedione | 上海埃农生物科技有限公司 | 2021-09-03 | — | — | CN | disclosed |
| CN-112028755-A | Method for preparing 1,3 cyclohexanedione | 青岛科技大学 | 2020-12-04 | — | — | CN | disclosed |
| CN-112028755-A | Method for preparing 1,3 cyclohexanedione | 青岛科技大学 | 2020-12-04 | — | — | CN | disclosed |
| US-10017605-B2 | Foam compositions | Gaco Western, LLC (US) | 2018-07-10 | — | — | US | disclosed |
| US-9631142-B2 | Piperidine derivative, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2017-04-25 | — | — | US | disclosed |
| US-20160272754-A1 | FOAM COMPOSITIONS | AMRIZE TECHNOLOGY SWITZERLAND LLC (CH) | 2016-09-22 | — | — | US | disclosed |
| US-9359471-B2 | Foam compositions | Gaco Western, LLC (US) | 2016-06-07 | — | — | US | disclosed |
| US-20160090534-A1 | PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-03-31 | — | — | US | disclosed |
| EP-2087058-A2 | RELEASE SHEETS AND METHODS OF MAKING THE SAME | S.D. Warren Company (US) | 2009-08-12 | — | — | EP | disclosed |
| WO-2008055026-A2 | RELEASE SHEETS AND METHODS OF MAKING THE SAME | S.D. WARREN COMPANY (US) | 2008-05-08 | — | — | WO | disclosed |
| WO-2008055026-A2 | RELEASE SHEETS AND METHODS OF MAKING THE SAME | S.D. WARREN COMPANY (US) | 2008-05-08 | — | — | WO | disclosed |
| US-20080102271-A1 | Release sheets and methods of making the same | S.D. WARREN COMPANY | 2008-05-01 | — | — | US | disclosed |
| US-20080102271-A1 | Release sheets and methods of making the same | S.D. WARREN COMPANY | 2008-05-01 | — | — | US | disclosed |
| EP-0900230-B1 | ESCULETIN DERIVATIVES | IDG UK LTD (GB) | 2001-12-12 | — | — | EP | disclosed |
| US-6287798-B1 | COMPOUND WHICH IS HYDROLYZABLE BY MICROORGANISMS FOR DETECTION IN SAMPLES; FORMS BLACK, INSOLUBLE, NONDIFFUSABLE COMPOUND | IDG (UK) LIMITED (GB) | 2001-09-11 | — | — | US | disclosed |
| US-6008008-A | 6- OR 7-SUBSTITUTED DERIVATIVES WHICH ARE MICROBIALLY HYDROLYZABLE TO FLUORESCENT, IRON CHELATING MOIETIES WHICH ARE NONDIFFUSING IN AGAR AND OTHER AQUEOUS ENVIRONMENTS; FOR DETECTION OF MICROORGANISMS | IDG (UK) LIMITED (GB) | 1999-12-28 | — | — | US | disclosed |
| EP-0900230-A2 | ESCULETIN DERIVATIVES | IDG (UK) Limited (GB) | 1999-03-10 | — | — | EP | disclosed |
| WO-1997041138-A2 | ESCULETIN DERIVATIVES | IDG (UK) LIMITED (GB) | 1997-11-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160090534-A1 | PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | MBD2, SSB, MBTD1 | TSHR 3128/4885SLC1A1 3221/4885MGAM 4272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.